OpenAI has introduced a new feature called ChatGPT Health in the United States, designed to analyze users' medical records alongside data from health apps such as MyFitnessPal. This feature aims to deliver personalized health advice based on the information provided. OpenAI has stated that interactions within ChatGPT Health will be stored separately from other conversations and will not be utilized for training its AI models. The company clarified that this tool is not intended for medical diagnosis or treatment.
Concerns have been raised regarding the privacy of users' health data. Andrew Crawford from the Center for Democracy and Technology emphasized the importance of stringent safeguards to protect sensitive health information. He noted that while the potential for enhanced patient empowerment exists, the risks associated with handling health data are significant. The discussion around privacy is particularly relevant as OpenAI explores advertising as a potential business model.
More than 230 million users reportedly engage with OpenAI's chatbot weekly, seeking information about health and wellness. The new feature is being positioned as a trusted source for health queries, with some industry experts describing its launch as a pivotal moment for both patient care and retail health solutions.
Currently, ChatGPT Health is only available to a select group of early users in the U.S., and there is no timeline for its introduction in the UK or other regions with strict data protection regulations, such as Switzerland and the European Economic Area. Concerns about the collection and sharing of health data by companies that may not be subject to stringent privacy protections have also been highlighted. Ultimately, OpenAI's initiative represents a significant development in the intersection of AI technology and healthcare.